A Falcone, C A Bodenizza, P Musto, M Carotenuto. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » AdultAntineoplastic Agents/adverse effectsAntineoplastic Agents/therapeutic useCreatine Kinase/metabolismHumansInterferon Type I/adverse effectsInterferon Type I/therapeutic useIsoenzymesLeukemia, Myelogenous, Chronic, BCR-ABL Positive/complicationsLeukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapyMalePolymyositis/chemically inducedPolymyositis/enzymologyPolymyositis/etiologyRecombinant Proteins
Substances： See more » Antineoplastic AgentsInterferon Type IIsoenzymesRecombinant ProteinsCreatine Kinase
Year: 1998 PMID： 9697894 DOI： 10.1038/sj.leu.2401104
Source DB: PubMed Journal: Leukemia ISSN： 0887-6924 Impact factor: 11.528